China National Medicines Corp Ltd (600511) — Cash Flow Reinvestment Rate
China National Medicines Corp Ltd (600511) has a Cash Flow Reinvestment Rate of 0.11x as of June 2025, reinvesting CN¥42.55 Million (capex CN¥13.23 Million plus investments CN¥29.33 Million) from operating cash flow of CN¥382.74 Million. Check China National Medicines Corp Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Medicines Corp Ltd Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for China National Medicines Corp Ltd across 22 annual periods. Explore 600511 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for China National Medicines Corp Ltd (2002–2024)
Year-by-year capital reinvestment analysis for China National Medicines Corp Ltd. For live market cap and broader valuation context, see 600511 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥177.45 Million | CN¥1.66 Billion | CN¥130.77 Million | ▲ +6.3% |
| 2023 | 0.10x | CN¥274.44 Million | CN¥2.73 Billion | CN¥145.12 Million | ▼ -14.5% |
| 2022 | 0.12x | CN¥282.10 Million | CN¥2.40 Billion | CN¥129.78 Million | ▲ +108.0% |
| 2021 | 0.06x | CN¥110.82 Million | CN¥1.96 Billion | CN¥95.07 Million | ▲ +2.5% |
| 2020 | 0.06x | CN¥71.92 Million | CN¥1.30 Billion | CN¥69.05 Million | ▲ +13.3% |
| 2019 | 0.05x | CN¥86.62 Million | CN¥1.78 Billion | CN¥85.72 Million | ▼ -75.2% |
| 2018 | 0.20x | CN¥192.66 Million | CN¥981.65 Million | CN¥132.46 Million | ▲ +79.3% |
| 2017 | 0.11x | CN¥117.63 Million | CN¥1.07 Billion | CN¥73.25 Million | ▼ -20.3% |
| 2016 | 0.14x | CN¥81.25 Million | CN¥591.25 Million | CN¥39.88 Million | ▼ -11.8% |
| 2015 | 0.16x | CN¥68.62 Million | CN¥440.29 Million | CN¥68.47 Million | ▼ -77.0% |
| 2014 | 0.68x | CN¥148.22 Million | CN¥218.94 Million | CN¥148.22 Million | ▲ +3.3% |
| 2013 | 0.66x | CN¥121.66 Million | CN¥185.56 Million | CN¥121.66 Million | ▼ -28.2% |
| 2012 | 0.91x | CN¥169.65 Million | CN¥185.87 Million | CN¥169.65 Million | ▲ +1105.7% |
| 2010 | 0.08x | CN¥24.09 Million | CN¥318.21 Million | CN¥24.09 Million | ▼ -13.5% |
| 2009 | 0.09x | CN¥22.33 Million | CN¥255.18 Million | CN¥22.33 Million | ▲ +17.2% |
| 2008 | 0.07x | CN¥16.21 Million | CN¥217.10 Million | CN¥16.21 Million | ▼ -31.1% |
| 2007 | 0.11x | CN¥8.61 Million | CN¥79.48 Million | CN¥8.61 Million | ▼ -44.7% |
| 2006 | 0.20x | CN¥23.81 Million | CN¥121.50 Million | CN¥23.81 Million | ▼ -56.2% |
| 2005 | 0.45x | CN¥41.24 Million | CN¥92.20 Million | CN¥41.24 Million | ▼ -74.7% |
| 2004 | 1.77x | CN¥87.08 Million | CN¥49.18 Million | CN¥87.08 Million | ▼ -99.0% |
| 2003 | 172.79x | CN¥90.92 Million | CN¥526.15K | CN¥90.92 Million | ▲ +18401.7% |
| 2002 | 0.93x | CN¥14.19 Million | CN¥15.19 Million | CN¥14.19 Million | — |